Loading…

Comparison of the novel quantitative ARMS assay and an enriched PCR–ASO assay for K-ras mutations with conventional cytology on endobiliary brush cytology from 312 consecutive extrahepatic biliary stenoses

Background: Extrahepatic biliary stenosis (EBS) has malignant and benign causes. Patients with EBS are at risk of having or developing malignancy. Accurate diagnostic tests for early detection and surveillance are needed. The sensitivity of biliary cytology for malignancy is low. K-ras mutation anal...

Full description

Saved in:
Bibliographic Details
Published in:Journal of clinical pathology 2005-12, Vol.58 (12), p.1315-1320
Main Authors: van Heek, N T, Clayton, S J, Sturm, P D J, Walker, J, Gouma, D J, Noorduyn, L A, Offerhaus, G J A, Fox, J C
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-b513t-a09c1be30f67e0355a84de07334a0a2b875fb12429f85cbd099de1d6527331973
cites cdi_FETCH-LOGICAL-b513t-a09c1be30f67e0355a84de07334a0a2b875fb12429f85cbd099de1d6527331973
container_end_page 1320
container_issue 12
container_start_page 1315
container_title Journal of clinical pathology
container_volume 58
creator van Heek, N T
Clayton, S J
Sturm, P D J
Walker, J
Gouma, D J
Noorduyn, L A
Offerhaus, G J A
Fox, J C
description Background: Extrahepatic biliary stenosis (EBS) has malignant and benign causes. Patients with EBS are at risk of having or developing malignancy. Accurate diagnostic tests for early detection and surveillance are needed. The sensitivity of biliary cytology for malignancy is low. K-ras mutation analysis on brush cytology is a valuable adjunct, but specificity is low. A quantitative test for K-ras mutations has been developed: the amplification refractory mutation system (ARMS). Aim: To assess the test characteristics and additional value of ARMS in diagnosing the cause of EBS. Methods: Brush samples from endoscopic retrograde cholangiopancreatography were collected from 312 patients with EBS. K-ras mutation analysis was performed using ARMS—allele specific amplification was coupled with real time fluorescent detection of PCR products. Results were compared with conventional cytology and K-ras mutation analysis using allele specific oligonucleotide (ASO) hybridisation, and evaluated in view of the final diagnosis. Results: The test characteristics of ARMS and ASO largely agreed. Sensitivity for detecting malignancy was 49% and 42%, specificity 93% and 88%, and positive predictive value (PPV) 96% and 91%, respectively. The sensitivity of ARMS and cytology combined was 71%, and PPV was 93%. The specificity of ARMS could be increased to 100% by setting limits for the false positives, but reduced sensitivity from 49% to 43%. Conclusions: ARMS can be considered supplementary to conventional cytology, and comparable to ASO in diagnosing malignant EBS. A specificity of 100% can be achieved with ARMS, which should be considered in the surveillance of patients at risk for pancreatic cancer.
doi_str_mv 10.1136/jcp.2004.022707
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1770790</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>847432660</sourcerecordid><originalsourceid>FETCH-LOGICAL-b513t-a09c1be30f67e0355a84de07334a0a2b875fb12429f85cbd099de1d6527331973</originalsourceid><addsrcrecordid>eNqFks1u1DAUhSMEoqWwZocsIUBCytR_sZMN0pACRbQUdYCt5ThOx0NiT-1k6Ox4Bx6Md-BJcJihAyxgYVny_c7xvfZJkvsIThAi7HChlhMMIZ1AjDnkN5J9RDlOKaLsZrIPIUZpwSnbS-6EsIAQEY7I7WQPMRLlGd1PvpWuW0pvgrPANaCfa2DdSrfgcpC2N73szUqD6fnpDMgQ5BpIW8cFtPVGzXUN3pXn3798nc7OtvXGefAm9TKAbhjVzgbw2fRzoJxdaTseyBaode9ad7EGbrSqXWVaI_0aVH4I81218a4DBOFRHLQafjajr3ov53oZzRX4JQy9ti7ocDe51cg26Hvb_SD58PLF-_I4PTl79bqcnqRVhkifSlgoVGkCG8Y1JFkmc1pryAmhEkpc5TxrKoQpLpo8U1UNi6LWqGYZjggqODlInm18l0PV6VrFybxsxdKbLrYjnDTiz4o1c3HhVgLx-E8FjAZPtgbeXQ469KIzQem2lVa7IYicckowYyP5-J8ky3NSYEYi-PAvcOEGH587xFtzBDEr-Gh3uKGUdyF43Vw3jaAYQyViqMQYKrEJVVQ8-H3WHb9NUQQebQEZlGwbL60yYcdxQlmORqN0w5n4XVfXdek_CcYJz8Tbj6U4ymfwuDw9Es8j_3TDV93iv13-ADk69lU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1781026970</pqid></control><display><type>article</type><title>Comparison of the novel quantitative ARMS assay and an enriched PCR–ASO assay for K-ras mutations with conventional cytology on endobiliary brush cytology from 312 consecutive extrahepatic biliary stenoses</title><source>PubMed Central Free</source><creator>van Heek, N T ; Clayton, S J ; Sturm, P D J ; Walker, J ; Gouma, D J ; Noorduyn, L A ; Offerhaus, G J A ; Fox, J C</creator><creatorcontrib>van Heek, N T ; Clayton, S J ; Sturm, P D J ; Walker, J ; Gouma, D J ; Noorduyn, L A ; Offerhaus, G J A ; Fox, J C</creatorcontrib><description>Background: Extrahepatic biliary stenosis (EBS) has malignant and benign causes. Patients with EBS are at risk of having or developing malignancy. Accurate diagnostic tests for early detection and surveillance are needed. The sensitivity of biliary cytology for malignancy is low. K-ras mutation analysis on brush cytology is a valuable adjunct, but specificity is low. A quantitative test for K-ras mutations has been developed: the amplification refractory mutation system (ARMS). Aim: To assess the test characteristics and additional value of ARMS in diagnosing the cause of EBS. Methods: Brush samples from endoscopic retrograde cholangiopancreatography were collected from 312 patients with EBS. K-ras mutation analysis was performed using ARMS—allele specific amplification was coupled with real time fluorescent detection of PCR products. Results were compared with conventional cytology and K-ras mutation analysis using allele specific oligonucleotide (ASO) hybridisation, and evaluated in view of the final diagnosis. Results: The test characteristics of ARMS and ASO largely agreed. Sensitivity for detecting malignancy was 49% and 42%, specificity 93% and 88%, and positive predictive value (PPV) 96% and 91%, respectively. The sensitivity of ARMS and cytology combined was 71%, and PPV was 93%. The specificity of ARMS could be increased to 100% by setting limits for the false positives, but reduced sensitivity from 49% to 43%. Conclusions: ARMS can be considered supplementary to conventional cytology, and comparable to ASO in diagnosing malignant EBS. A specificity of 100% can be achieved with ARMS, which should be considered in the surveillance of patients at risk for pancreatic cancer.</description><identifier>ISSN: 0021-9746</identifier><identifier>EISSN: 1472-4146</identifier><identifier>DOI: 10.1136/jcp.2004.022707</identifier><identifier>PMID: 16311354</identifier><identifier>CODEN: JCPAAK</identifier><language>eng</language><publisher>London: BMJ Publishing Group Ltd and Association of Clinical Pathologists</publisher><subject>Adult ; Aged ; Aged, 80 and over ; allele specific oligonucleotide ; amplification refractory mutation system ; ARMS ; ASO ; Biliary Tract Neoplasms - complications ; Biliary Tract Neoplasms - diagnosis ; Biological and medical sciences ; brush cytology ; Cholangiopancreatography, Endoscopic Retrograde ; Cholestasis, Extrahepatic - etiology ; Cytodiagnosis ; DNA Mutational Analysis - methods ; DNA, Neoplasm - genetics ; EBS ; endoscopic retrograde cholangiopancreatography ; ERCP ; extrahepatic biliary stenosis ; Female ; Genes, ras ; Humans ; Investigative techniques, diagnostic techniques (general aspects) ; K-ras ; Male ; Medical sciences ; Middle Aged ; Mutation ; Original ; Pancreatic Neoplasms - complications ; Pancreatic Neoplasms - diagnosis ; Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques ; PCR ; polymerase chain reaction ; Polymerase Chain Reaction - methods ; Sensitivity and Specificity</subject><ispartof>Journal of clinical pathology, 2005-12, Vol.58 (12), p.1315-1320</ispartof><rights>Copyright 2005 Journal of Clinical Pathology</rights><rights>2006 INIST-CNRS</rights><rights>Copyright: 2005 Copyright 2005 Journal of Clinical Pathology</rights><rights>Copyright © Copyright 2005 Journal of Clinical Pathology 2005</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b513t-a09c1be30f67e0355a84de07334a0a2b875fb12429f85cbd099de1d6527331973</citedby><cites>FETCH-LOGICAL-b513t-a09c1be30f67e0355a84de07334a0a2b875fb12429f85cbd099de1d6527331973</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1770790/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1770790/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=17346817$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16311354$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>van Heek, N T</creatorcontrib><creatorcontrib>Clayton, S J</creatorcontrib><creatorcontrib>Sturm, P D J</creatorcontrib><creatorcontrib>Walker, J</creatorcontrib><creatorcontrib>Gouma, D J</creatorcontrib><creatorcontrib>Noorduyn, L A</creatorcontrib><creatorcontrib>Offerhaus, G J A</creatorcontrib><creatorcontrib>Fox, J C</creatorcontrib><title>Comparison of the novel quantitative ARMS assay and an enriched PCR–ASO assay for K-ras mutations with conventional cytology on endobiliary brush cytology from 312 consecutive extrahepatic biliary stenoses</title><title>Journal of clinical pathology</title><addtitle>J Clin Pathol</addtitle><description>Background: Extrahepatic biliary stenosis (EBS) has malignant and benign causes. Patients with EBS are at risk of having or developing malignancy. Accurate diagnostic tests for early detection and surveillance are needed. The sensitivity of biliary cytology for malignancy is low. K-ras mutation analysis on brush cytology is a valuable adjunct, but specificity is low. A quantitative test for K-ras mutations has been developed: the amplification refractory mutation system (ARMS). Aim: To assess the test characteristics and additional value of ARMS in diagnosing the cause of EBS. Methods: Brush samples from endoscopic retrograde cholangiopancreatography were collected from 312 patients with EBS. K-ras mutation analysis was performed using ARMS—allele specific amplification was coupled with real time fluorescent detection of PCR products. Results were compared with conventional cytology and K-ras mutation analysis using allele specific oligonucleotide (ASO) hybridisation, and evaluated in view of the final diagnosis. Results: The test characteristics of ARMS and ASO largely agreed. Sensitivity for detecting malignancy was 49% and 42%, specificity 93% and 88%, and positive predictive value (PPV) 96% and 91%, respectively. The sensitivity of ARMS and cytology combined was 71%, and PPV was 93%. The specificity of ARMS could be increased to 100% by setting limits for the false positives, but reduced sensitivity from 49% to 43%. Conclusions: ARMS can be considered supplementary to conventional cytology, and comparable to ASO in diagnosing malignant EBS. A specificity of 100% can be achieved with ARMS, which should be considered in the surveillance of patients at risk for pancreatic cancer.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>allele specific oligonucleotide</subject><subject>amplification refractory mutation system</subject><subject>ARMS</subject><subject>ASO</subject><subject>Biliary Tract Neoplasms - complications</subject><subject>Biliary Tract Neoplasms - diagnosis</subject><subject>Biological and medical sciences</subject><subject>brush cytology</subject><subject>Cholangiopancreatography, Endoscopic Retrograde</subject><subject>Cholestasis, Extrahepatic - etiology</subject><subject>Cytodiagnosis</subject><subject>DNA Mutational Analysis - methods</subject><subject>DNA, Neoplasm - genetics</subject><subject>EBS</subject><subject>endoscopic retrograde cholangiopancreatography</subject><subject>ERCP</subject><subject>extrahepatic biliary stenosis</subject><subject>Female</subject><subject>Genes, ras</subject><subject>Humans</subject><subject>Investigative techniques, diagnostic techniques (general aspects)</subject><subject>K-ras</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Mutation</subject><subject>Original</subject><subject>Pancreatic Neoplasms - complications</subject><subject>Pancreatic Neoplasms - diagnosis</subject><subject>Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques</subject><subject>PCR</subject><subject>polymerase chain reaction</subject><subject>Polymerase Chain Reaction - methods</subject><subject>Sensitivity and Specificity</subject><issn>0021-9746</issn><issn>1472-4146</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNqFks1u1DAUhSMEoqWwZocsIUBCytR_sZMN0pACRbQUdYCt5ThOx0NiT-1k6Ox4Bx6Md-BJcJihAyxgYVny_c7xvfZJkvsIThAi7HChlhMMIZ1AjDnkN5J9RDlOKaLsZrIPIUZpwSnbS-6EsIAQEY7I7WQPMRLlGd1PvpWuW0pvgrPANaCfa2DdSrfgcpC2N73szUqD6fnpDMgQ5BpIW8cFtPVGzXUN3pXn3798nc7OtvXGefAm9TKAbhjVzgbw2fRzoJxdaTseyBaode9ad7EGbrSqXWVaI_0aVH4I81218a4DBOFRHLQafjajr3ov53oZzRX4JQy9ti7ocDe51cg26Hvb_SD58PLF-_I4PTl79bqcnqRVhkifSlgoVGkCG8Y1JFkmc1pryAmhEkpc5TxrKoQpLpo8U1UNi6LWqGYZjggqODlInm18l0PV6VrFybxsxdKbLrYjnDTiz4o1c3HhVgLx-E8FjAZPtgbeXQ469KIzQem2lVa7IYicckowYyP5-J8ky3NSYEYi-PAvcOEGH587xFtzBDEr-Gh3uKGUdyF43Vw3jaAYQyViqMQYKrEJVVQ8-H3WHb9NUQQebQEZlGwbL60yYcdxQlmORqN0w5n4XVfXdek_CcYJz8Tbj6U4ymfwuDw9Es8j_3TDV93iv13-ADk69lU</recordid><startdate>20051201</startdate><enddate>20051201</enddate><creator>van Heek, N T</creator><creator>Clayton, S J</creator><creator>Sturm, P D J</creator><creator>Walker, J</creator><creator>Gouma, D J</creator><creator>Noorduyn, L A</creator><creator>Offerhaus, G J A</creator><creator>Fox, J C</creator><general>BMJ Publishing Group Ltd and Association of Clinical Pathologists</general><general>BMJ</general><general>BMJ Publishing Group LTD</general><general>Copyright 2005 Journal of Clinical Pathology</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>7TO</scope><scope>H94</scope><scope>5PM</scope></search><sort><creationdate>20051201</creationdate><title>Comparison of the novel quantitative ARMS assay and an enriched PCR–ASO assay for K-ras mutations with conventional cytology on endobiliary brush cytology from 312 consecutive extrahepatic biliary stenoses</title><author>van Heek, N T ; Clayton, S J ; Sturm, P D J ; Walker, J ; Gouma, D J ; Noorduyn, L A ; Offerhaus, G J A ; Fox, J C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b513t-a09c1be30f67e0355a84de07334a0a2b875fb12429f85cbd099de1d6527331973</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>allele specific oligonucleotide</topic><topic>amplification refractory mutation system</topic><topic>ARMS</topic><topic>ASO</topic><topic>Biliary Tract Neoplasms - complications</topic><topic>Biliary Tract Neoplasms - diagnosis</topic><topic>Biological and medical sciences</topic><topic>brush cytology</topic><topic>Cholangiopancreatography, Endoscopic Retrograde</topic><topic>Cholestasis, Extrahepatic - etiology</topic><topic>Cytodiagnosis</topic><topic>DNA Mutational Analysis - methods</topic><topic>DNA, Neoplasm - genetics</topic><topic>EBS</topic><topic>endoscopic retrograde cholangiopancreatography</topic><topic>ERCP</topic><topic>extrahepatic biliary stenosis</topic><topic>Female</topic><topic>Genes, ras</topic><topic>Humans</topic><topic>Investigative techniques, diagnostic techniques (general aspects)</topic><topic>K-ras</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Mutation</topic><topic>Original</topic><topic>Pancreatic Neoplasms - complications</topic><topic>Pancreatic Neoplasms - diagnosis</topic><topic>Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques</topic><topic>PCR</topic><topic>polymerase chain reaction</topic><topic>Polymerase Chain Reaction - methods</topic><topic>Sensitivity and Specificity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>van Heek, N T</creatorcontrib><creatorcontrib>Clayton, S J</creatorcontrib><creatorcontrib>Sturm, P D J</creatorcontrib><creatorcontrib>Walker, J</creatorcontrib><creatorcontrib>Gouma, D J</creatorcontrib><creatorcontrib>Noorduyn, L A</creatorcontrib><creatorcontrib>Offerhaus, G J A</creatorcontrib><creatorcontrib>Fox, J C</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of clinical pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>van Heek, N T</au><au>Clayton, S J</au><au>Sturm, P D J</au><au>Walker, J</au><au>Gouma, D J</au><au>Noorduyn, L A</au><au>Offerhaus, G J A</au><au>Fox, J C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparison of the novel quantitative ARMS assay and an enriched PCR–ASO assay for K-ras mutations with conventional cytology on endobiliary brush cytology from 312 consecutive extrahepatic biliary stenoses</atitle><jtitle>Journal of clinical pathology</jtitle><addtitle>J Clin Pathol</addtitle><date>2005-12-01</date><risdate>2005</risdate><volume>58</volume><issue>12</issue><spage>1315</spage><epage>1320</epage><pages>1315-1320</pages><issn>0021-9746</issn><eissn>1472-4146</eissn><coden>JCPAAK</coden><abstract>Background: Extrahepatic biliary stenosis (EBS) has malignant and benign causes. Patients with EBS are at risk of having or developing malignancy. Accurate diagnostic tests for early detection and surveillance are needed. The sensitivity of biliary cytology for malignancy is low. K-ras mutation analysis on brush cytology is a valuable adjunct, but specificity is low. A quantitative test for K-ras mutations has been developed: the amplification refractory mutation system (ARMS). Aim: To assess the test characteristics and additional value of ARMS in diagnosing the cause of EBS. Methods: Brush samples from endoscopic retrograde cholangiopancreatography were collected from 312 patients with EBS. K-ras mutation analysis was performed using ARMS—allele specific amplification was coupled with real time fluorescent detection of PCR products. Results were compared with conventional cytology and K-ras mutation analysis using allele specific oligonucleotide (ASO) hybridisation, and evaluated in view of the final diagnosis. Results: The test characteristics of ARMS and ASO largely agreed. Sensitivity for detecting malignancy was 49% and 42%, specificity 93% and 88%, and positive predictive value (PPV) 96% and 91%, respectively. The sensitivity of ARMS and cytology combined was 71%, and PPV was 93%. The specificity of ARMS could be increased to 100% by setting limits for the false positives, but reduced sensitivity from 49% to 43%. Conclusions: ARMS can be considered supplementary to conventional cytology, and comparable to ASO in diagnosing malignant EBS. A specificity of 100% can be achieved with ARMS, which should be considered in the surveillance of patients at risk for pancreatic cancer.</abstract><cop>London</cop><pub>BMJ Publishing Group Ltd and Association of Clinical Pathologists</pub><pmid>16311354</pmid><doi>10.1136/jcp.2004.022707</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0021-9746
ispartof Journal of clinical pathology, 2005-12, Vol.58 (12), p.1315-1320
issn 0021-9746
1472-4146
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1770790
source PubMed Central Free
subjects Adult
Aged
Aged, 80 and over
allele specific oligonucleotide
amplification refractory mutation system
ARMS
ASO
Biliary Tract Neoplasms - complications
Biliary Tract Neoplasms - diagnosis
Biological and medical sciences
brush cytology
Cholangiopancreatography, Endoscopic Retrograde
Cholestasis, Extrahepatic - etiology
Cytodiagnosis
DNA Mutational Analysis - methods
DNA, Neoplasm - genetics
EBS
endoscopic retrograde cholangiopancreatography
ERCP
extrahepatic biliary stenosis
Female
Genes, ras
Humans
Investigative techniques, diagnostic techniques (general aspects)
K-ras
Male
Medical sciences
Middle Aged
Mutation
Original
Pancreatic Neoplasms - complications
Pancreatic Neoplasms - diagnosis
Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques
PCR
polymerase chain reaction
Polymerase Chain Reaction - methods
Sensitivity and Specificity
title Comparison of the novel quantitative ARMS assay and an enriched PCR–ASO assay for K-ras mutations with conventional cytology on endobiliary brush cytology from 312 consecutive extrahepatic biliary stenoses
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T10%3A15%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparison%20of%20the%20novel%20quantitative%20ARMS%20assay%20and%20an%20enriched%20PCR%E2%80%93ASO%20assay%20for%20K-ras%20mutations%20with%20conventional%20cytology%20on%20endobiliary%20brush%20cytology%20from%20312%20consecutive%20extrahepatic%20biliary%20stenoses&rft.jtitle=Journal%20of%20clinical%20pathology&rft.au=van%20Heek,%20N%20T&rft.date=2005-12-01&rft.volume=58&rft.issue=12&rft.spage=1315&rft.epage=1320&rft.pages=1315-1320&rft.issn=0021-9746&rft.eissn=1472-4146&rft.coden=JCPAAK&rft_id=info:doi/10.1136/jcp.2004.022707&rft_dat=%3Cproquest_pubme%3E847432660%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b513t-a09c1be30f67e0355a84de07334a0a2b875fb12429f85cbd099de1d6527331973%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1781026970&rft_id=info:pmid/16311354&rfr_iscdi=true